Condition: Depression - Major Depressive Disorder · Sponsor: Ionclinics & Deionic SL
The purpose of this randomized controlled trial is to investigate the non-inferiority, and possible superiority, of a high-dose home-based tDCS protocol compared with a conventional home-based protocol, and to assess its cost-effectiveness, in patients with major depression. As a secondary aim, we aim to assess the predictive value of baseline EEG for clinical response to high-dose home-based tDCS treatment in patients with major depression.
This description comes directly from the study's public registry record.
Ane Miren Gutiérrez Muto, PhD · +34960606200 · investigacion@ionclinics.com
Ensayos Ionclinics · +34674059324 · ensayos@ionclinics.com
Always discuss trial participation with your own doctor first.
| Hospital Universiatrio Doctor Peset | Valencia, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07611773